Vergent Bioscience

We are a biotech company developing innovative molecular imaging probes for life science research, pharmaceutical development, and clinical diagnostics. Our imaging probes detect cell death (specifically apoptosis) and inflammation in disease, with applications in screening, toxicology, and efficacy studies. We also develop potent enzyme inhibitors that are useful for elucidating mechanisms in cell biology, and may also have clinical therapeutic potential in difficult to treat diseases. Research: Our customers include academic and medical research institutes, pharmaceutical companies, government agencies, and contract research organizations (CROs). Apoptosis and inflammation are important to many areas of biological research, and our imaging probes and enzyme inhibitors provide critical information during screening, toxicology, and efficacy studies. Clinical: We endeavor to bring our imaging probes and enzyme inhibitor technologies into the clinic to detect, diagnose, and treat human disease. Detecting apoptosis and inflammation will help healthcare professionals better address toxicity and tissue damage, while also enabling the development of novel therapeutics. We invite you to follow our progress by checking out our Clinical Opportunities page.